Literature DB >> 24750352

Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.

Mohammadhassan Mirbolouk1, Samaneh Asgari, Farhad Sheikholeslami, Fardin Mirbolouk, Fereidoun Azizi, Farzad Hadaegh.   

Abstract

AIM: To determine the impact of body mass index and the presence of metabolic syndrome (MetS) on cardiovascular disease (CVD) and mortality events in an elderly Tehranian population.
METHODS: A population-based cohort of 1199 participants aged ≥65 years were followed for a mean of 9.74 years. Participants were stratified according to body mass index categories and MetS status. Cox regression analyses were used to estimate the hazard ratio of CVD and mortality events, given overweight participants without MetS as reference. RESULT: During follow up, 271 CVD events and 239 deaths (106 CVD deaths) occurred. Regarding CVD, multivariate-adjusted hazard ratios for CVD events in normal weight and obese participants without MetS were 1.21 (95% CI 0.77-1.91) and 1.46 (95% CI 0.64-3.34), respectively, and for normal weight, overweight and obese participants with MetS were 2.07 (95% CI 1.23-3.28), 1.72 (95% CI 1.13-2.62), and 1.53 (95% CI 0.95-2.45), respectively. Corresponding hazard ratios for CVD mortality were 2.08 (95% CI 0.93-4.82), 1.07 (95% CI 0.13-8.78), 3.71 (95% CI 1.55-8.85), 2.42 (95% CI 1.06-5.51) and 3.31 (95% CI 1.39-7.88), and for all-cause mortality were 1.41 (95% CI 0.9-2.23), 1.33 (95% CI 0.51-3.47), 1.84 (95% CI 1.1-3.09), 1.46 (95% CI 0.93-2.34) and 1.5 (95% CI 0.91-2.56), respectively. In the presence of diabetes in place of MetS, all of the diabetic participants regardless of body mass index category highlighted a significant risk for CVD and mortality events.
CONCLUSION: Among the elderly population, the presence of MetS was necessary for exploring the risk of CVD events and its mortality; however, only the normal weight population with MetS had a significant risk for all-cause mortality
© 2014 Japan Geriatrics Society.

Entities:  

Keywords:  aged; cardiovascular disease; metabolic syndrome X; obesity

Mesh:

Substances:

Year:  2014        PMID: 24750352     DOI: 10.1111/ggi.12295

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  5 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: The Brazilian study on healthy aging.

Authors:  Lara Roberson; Sameer Shaharyar; Ehimen Aneni; Wladimir Freitas; Michael Blaha; Arthur Agatston; Roger Blumenthal; Raul D Santos; Hamid Feiz; Khurram Nasir; Andrei Sposito
Journal:  Diabetol Metab Syndr       Date:  2014-11-07       Impact factor: 3.320

3.  Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients.

Authors:  Samaneh Akbarpour; Davood Khalili; Hojjat Zeraati; Mohammad Ali Mansournia; Azra Ramezankhani; Akbar Fotouhi
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

4.  BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants.

Authors:  Dagfinn Aune; Abhijit Sen; Manya Prasad; Teresa Norat; Imre Janszky; Serena Tonstad; Pål Romundstad; Lars J Vatten
Journal:  BMJ       Date:  2016-05-04

Review 5.  The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article.

Authors:  Hanli Lin; Liqun Zhang; Ruizhi Zheng; Yishan Zheng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.